JNJ

rhoan0142

72% YTD. Mostly wheeling CAD equities, and some safe US stocks. CAD side mainly wheeled BAM, SLF, CLS, CNR US side V, GOOG, JNJ, PEP. And make a decent chunk of change trading RDDT.

Always_Curious_One2

SMWB - 100% subscription revenues (half are Multi year), 80% gross margins and mid teens growth. They are a Key Data business that helps large global corporations understand their competitive position, and what their toughest competitors are doing. Their data is Unique as they collect Real Time every minute of every day the activity across global websites, browsers, mobile apps, search engines, and now generative AI driven traffic. These data are hugely valuable to enterprises from JNJ to Coke to JPM to S&P Global to Bloomberg to Google to Samsung to Apple to Disney to Eli Lilly … And the AI platforms also license SMWB data to perform their analytics. Operating margins are scaling Up as they grow their recurring revenues — with 25% EBIT (that’s right EBIT, not EBITDA) visible in the 4 year time frame. SMWB is not well covered (no one has estimates past 2027) — but with their unique data subscriptions growth and profit drop down they’ll be earning over $1 of Cash EPS in a 4 year time frame. They are not capital expenditures dependent. AI is actually helping them spend less on SG&A on the opex side. With their high margins, light capital requirements, and growing Recurring revenues — they should get at least a 20 multiple (many such businesses get 30X). So the stock should be $25-30 in a few years versus $7.45 now. Also, Adobe acquired SemRush (an SEO only company with less analytics than SMWB) for $1.9 billion in cash !! SMWB provides more value to clients, and is currently only a $618 million market cap - so an acquisition is a possibility. I am not pitching that as a preferred outcome but it sure does provide downside protection.

BeneficialQuality899

Google search dividend kings or aristocrats. I like KO, JNJ, NUE, and WMT

BootGroundbreaking50

Bought UNH 350 1-27-27 leaps @ 32.71 up 91.24% bought them 8-6-25 bought JNJ 180 Jan 16-2026 on 8-29-25 up 386.33% both stocks were hit with bad news at the time.

TheWatchman1991

Thank you. I've been adding a lot this year into Google, GEV, CEG and a little more Joby. Sold JNJ and GEHC. PEP has been crap but I'm just collecting the dividend. I haven't added too much to MSFT besides a few shares in April. I'd like to see MSFT go closer to 450$.

BeneficialQuality899

JNJ is a dividend king. They aren’t going anywhere and will remain a leader

earth_man_7

JNJ

Plus_Seesaw2023

Why? Everyone bought this damn stock at between $60 and $70 minimum. They're all losing money! If the fundamentals change and Wall Street decides to buy this stock like JNJ or LLY, it could even return to $80 in the long term to fill the gap. This market is rigged, and that's just the way it is!

undergroundmusic69

JNJ @ 160 — used it to buy a car. Was really annoyed when it hit 215, but what ever, I needed a car 😂

starlordbg

I am currently scaling my position into a growth biotech stock, which is in fact my only stock for the time being, but I would go for obvious ones like KO, PEP, JNJ, PG, CL, WMT, some food giants, BRK.B and such.

tugrulthelol

My top 5 stock picks with no explanation: MU,WDC, LLY, JNJ, CHRW Just wanted to share with yall what my crystal ball had to say

Immediate-Result4068

Its actually better to take an "opportunity loss" and take a week off enjoy life clear your head so you can sleep then research and plan your next trades. You can't control your emotions if you are stressed. Emotions make for bad trades. size your positions smaller if you feel too much pressure about losses. Learn to read options tables they will tell you the expected move / volatility of a stock. stable ? JNJ Exxon IBM pick a low spot. put your money in enable dividend re-investment and enjoy your life check them each year. Fast Money is both earned and lost. Slightly more risky but you could do TLTW, USOI, and PFFA basically bonds oil and preferred stocks. USOI NAV has taken a beating but that's because oil has been. that won't stay that way forever ... TLTW roughly 16% Dividend not much NAV volatility USOI has been sinking with the Price of OIL but might be a good time to get in about 17% dividend PFFA stable and a 8 percent dividend. 10 years from now with no stress you will be happy. Wait for the next big 10 or 20 percent market crash and buy SPY or VOO or QQQ set and forget.

thinkneo

We've all been there. Panic selling feels like relief in the moment, then regret hits when you see the rebound. The good news: you didn't lose the money, you just moved to cash. The positions are still there to buy back. Yeah, you might pay a bit more, but that's tuition, not a disaster. For stable stocks that help you sleep: \- \*\*GOOGL / MSFT / AMZN\*\* - Big tech but less volatile than NVDA \- \*\*BRK.B\*\* - Buffett's portfolio, boring but steady \- \*\*COST / WMT\*\* - Consumer staples with pricing power \- \*\*Dividend aristocrats\*\* (JNJ, PG, KO) - Won't make you rich quick, but won't keep you up at night either The real fix is position sizing. If a normal pullback costs you sleep, you were probably too concentrated. Spread it out, size down, and the dips won't feel like emergencies.

GardenOk7022

Totally agree about sticking with quality stocks. I use moomoo to track long-term ROE and dividend consistency before entering any wheel trade. The earnings and valuation charts are easy to understand, and paired with their options analysis features, it gives me a lot more confidence to manage assignments calmly. Stocks like KO or JNJ may move slowly, but they bring steady results.

UptownSeries

JNJ has been crushing it lately

Timeoff98

Buy all red today BRK, JPM, WPM, JNJ and XOM, long on reverse AI

Difficult-Fix-5221

JNJ fuck you

drzz1y

This is an interesting spot on U. Ideally you’d want this area to hold 46-43. Might do a flush out, then hopefully a grind back to the upside. Weekly structure looks shaky. I’m thinking with poor AI sentiment, overall tech sector is going to lag for a bit while other sectors get more love. Look at ticker JNJ, this market isn’t a bearish market. Just rotational as tech has been the story for too long. And with ORCL and AVGO catalysts gone for the upside, it was a rotational, controlled selling on certain sectors. Ticker BAC hit ATH Friday since 2006. Need a catalyst to bring back tech flows. It’s been quite the opposite past few days inflows vs outflows on tech. Inshallah lambos and rari’s my bro. https://preview.redd.it/1lxu74mui97g1.jpeg?width=1320&format=pjpg&auto=webp&s=2cd3740f1ca04f2cf2c2885fd287f9ba05c13b7d

PerfectInAllThings

My LLY, MRK, UNH, JNJ, etc., are all up today

manitou202

Counter point: $JNJ up 45.82% $LLY up 29.73% $WMT up 28.36% $GS up 58.45% $CAT up 73.89% Tech Stocks $NFLX up only 6.11% $META up only 8.92% $AMZN up only 4.57% It's hard to pick individual winners. Sometimes it is better to stick with sector ETFs. For example, $FBCV (blue chip value stocks) up 15% for the year. Not that far behind the SP500 which is heavily driven by the Mag7. Blue chips are likely to hold up better in a major economic downturn or an AI bubble pop. Diversify. Don't put too much into one sector, or one stock. For every winner you pick you are just as likely to pick a loser that offsets your gains.

BigWarning8696

I can't find anything on it either. I suspect they may be bought out by MRK, JNJ, or LLY since they are also in the ulcerative colitis field, but that's just a guess. Looks like they are running out of money to finish their trials

EmpathyFabrication

Paxton back with more KVUE shenanigans. TX judge orders KVUE and JNJ to register with the Secretary of State. I assume this is Paxton's attempt to circumvent the jurisdiction issues he ran into with the court orders last month. https://www.bloomberg.com/news/articles/2025-12-08/tylenol-maker-isn-t-registered-to-operate-in-texas-judge-says

PalpitationSmooth992

check after hours VZ T ACI CVS JNJ on todays menu i keep telling you guys after hours is where its at

themarketapex

JPM back to 318, JNJ back to 205, it's stocks that start with J day

bigmeatbag

I'm in the Bahamas and just saw a dark skinned couple, and I mean dark like black as a piece of coal, spraying on sunscreen. Is that something new, is this a new market for sunscreen? Long JNJ?

mindmelder23

You ride the same stock for decades you have insanely high gain. I have relatives who had LLY,JNJ,XOM since the 90s- they did very well just get some big mega company like that and sit on it forever.

WaIlstreetBots

I don’t disagree, but I think a stock like PG or JNJ would fall a similar amount.

elvee61

Man, I overdid everything this weekend. Bought family-sized tubs of Tylenol and Ben Gay. Calls on JNJ.

IDrinkSulfuricAcid

C'monnnn JNJ you can do it you can turn green!

IDrinkSulfuricAcid

GOOGL, LLY, JNJ all down...but at least NVDA bagholders are going down with me, so I guess it's alright.

big_worm77

What is she in to? Proctor and gamble? JNJ? VOO?

Lopsided_Process5141

If you didn't boomer full port JNJ six months ago you are ghey

SmashAtoms_

WTF is JNJ doing

zooka19

JNJ surprised me this year ngl.

XorAndNot

man JNJ is on a run huh

MikeMcArdle

JNJ and BBAi

dangernext

Btw for the past month and a half, the real MVP has been J AND FUKING J 🤣🤣🤣 JNJ HAHAHA

greenpride32

>2. “Suspicious Revenue Recognition” >Burry warned that many AI companies may be using accounting methods that make their revenue look larger or more stable than it really is. >This can include: >Booking multi-year deals upfront This isn't true. A company can only record revenue after the service or product is delivered. This is general GAAP rules. In tech world, the commonly used term for contracted revenue that has not been delivered yet is remaining peformance obligation or RPO. For example, company X signs on to use MSFT Azure cloud for 5 years at $100m a year or $500m total. You might read some headline "company X signs $500m deal with MSFT". But only $25m will be required for each quarterly report. You will see companies such as MSFT AMZN GOOLG ORCL have RPO in the hundreds of billions. That's one of the reasons why these companies are megacaps - they have the likes of KO VZ WMT JNJ NFLX T lined up to pay them billions in future revenue - huge cashflow companies that aren't likely to fail any time soon is as solid as it gets.

Lopsided_Process5141

JNJ was the play just as I predicted

1989H27

I've done well today. JNJ, GOOG and ASML have been my big picks for the last year. Sold a big chunk of my SP500 tracker today near the top in case the market dumps on NVDA earnings, will buy in again tomorrow regardless of the price. I feel like slightly down is more likely than up. Might even buy some MSTR because you KNOW a dumb bounce is coming.

Old_Ape_General

$JNJ

DrSeuss1020

I can’t stand the people saying “how’d you lose a lot the market is only down 5%”. Oh I dunno bob, maybe because the highly speculative companies not named KO and JNJ got absolutely castrated in the last 3 weeks

EscapeHistorical178

TTWO DIS BA JNJ CRSP PLTR CALLS ON SPY, pull the trigger. MAKE MONEY, LFG.

No-Improvement3164

Look at JNJ. It took off as soon as mango mentioned it in Saudi

eyerollingsex

So Woody Johnson got outed in the Epstein emails and the market is crashing but JNJ is green 🧠

Trust_Know_Won

1. NVDA (Nvidia) Nvidia remains a key growth stock and the MVP of 2025, powering AI innovation and data center expansion, making it central to the tech sector’s secular momentum. Good for long-term growth and compounding potential. 2. JNJ (Johnson & Johnson) Johnson & Johnson offers reliable dividend growth, stability, and defensive sector exposure, suitable for investors seeking yield and inflation protection in an uncertain macro environment. 3. IREN (IREN Ltd) One of the year’s best-performing growth stocks, IREN exemplifies mid-cap momentum in digital infrastructure, up over 430% for 2025, ideal for adding innovation-driven upside to a portfolio. 4. EPD (Enterprise Products Partners) With a nearly 7% yield and steady cash flows from energy infrastructure, EPD provides dependable income as part of a barbell strategy balancing growth with dividend strength. 5. CLS (Celestica Inc.) Celestica has delivered among the top returns in 2025, benefiting from demand in electronics manufacturing and AI-related hardware integration, representing technology and industrial sector growth. This blend supports a diversified, risk-aware mix of US tech, dividend aristocrats, infrastructure, and high-growth innovators, matching the proposed strategy of both long-term compounding and tactical opportunity hunting.

tugrulthelol

Can someone tell me how JNJ pumped 2% today?

BanditoBoom

Yeah…but have you actually looked at the performance of the nifty fifty over the next decade? Yes SOME of those companies turned out to not be able to justify those high P/Es But SOME companies DID turn out to justify those high P/Es In fact from my perspective it was about 50/50 split Coca-Cola, Pepsi, JNJ, IBM, American Express, GE, and so on absolutely justified their high P/Es based on their performance since then. The only thing a high P/E tells you is that you have to be INCREDIBLY detailed in your analysis and investment thesis, and be extremely judicial in where you out your money.

Embarrassed-Care6130

Í own PEP, PG, and JNJ. They are not at 10-year lows, though PEP and PG have struggled recently. IYC (consumer discretionary) is up 176% (price return) or 198% (total return) since Oct 2015. IYK (consumer non-discretionary) is up 84%/131% over the same period. They have lagged the market considerably since 2021 but they are absolutely not down.

jgatt17

JNJ has grown their dividend for more consecutive years than you’ve been alive

thereal_scott_pruitt

Menin inhibitors are an excellent example of precision medicine - the issue is that the market for genetically defined translocations in AML is super small and Menin inhibitors don't have a role outside that market. A key piece of data you're missing is that JNJ has a Menin inhibitor they are still pushing through. It's curious why JNJ hasn't bought out Syndax yet... despite Syndax trying to be bought for the last several years. There might be some additional value that either Kura's drug has or bleximenib has that we don't see from public disclosures. Meanwhile, you also missed BioMea Fusion which has a Menin inhibitor (but it is trash and doesn't have signal in AML). BioMea swapped to cardiometabolic to chase the FOMO in that area, but don't expect JNJ, Syndax or Kura to follow into T2D or obesity because the mechanism is trash for Menin in those diseases (and because the people at BioMea are knuckleheads). I do expect Syndax sales to continue to rise, but the broader AML space is very competitive. They won't do nearly as well with marketing as a top 20 pharma would.

Sea-Frame4748

I look for blue chip stocks with consecutive dividends like KO and JNJ (dividend kings 50+ years). In my opinion, they are recession proof. I also have CVX with 38 years of consistent dividend payments.

MagnesiumKitten

JNJ doesn't seem like like it will grow much, maybe 2% for the year , and it's fairly priced O - Realty Income Corporation of San Diego? 2% undervalued, but it'll only make like 5% for the year there is debt so a moderate risk it's a good company overall, but good and bad stresses going on so the Financial Strength is mediocre but the revenues are going up along with the debt 13% volatility it is less jittery than the S&P500 though If things drop 10% with the S&P500, O will drop like 6% so not that jittery where Nvidia if things drop 10% they'll drop 22% if the market goes up 20% Nvidia goes up 44%

Rushmore9

Now they will get all the monies from NVO or JNJ or whomever. Maybe they were waiting for this moment

Ready_Scratch_1902

" time to buy JNJ " bottom signal

Johnny252525

Wells don’t ring at the top or bottom of the market. Did you know 100k investment in tqqq in 2010 is now worth 20 million dollars today ? Or also endured two separate Brutal 70 pct drawdowns along the way. That is crazy! Taking profits is smart for sure as we all obviously get another 10-20 pct correction in our lifetimes. As a matter of fact a 10 pct correction happens 2 out of 3 years. You did mention you had JNJ and think other big consumer staple stocks. NEVER sell those. As those divis compound you end up with insane amount of stock and when market does correct jnj , ko, pep , pg , cg , will almost all RISE in value. Never sell those. I read a report of a school teacher who loved Coca Cola bought 6k in 1990 and only added 6k a year to it and is now sitting on 4 million dollars and those stocks rarely have big drawdowns.

One-Brain6531

Realty and JNJ haven’t moved much Some European and US Stocks was in red And currency headwinds -13% YTD

One-Brain6531

Or as I had before, JNJ and O was even more stable +dividens But Done is done

Agitated-Fan3719

people stop speculating when the market gets spooked and go to safe stocks like Procter & Gamble (P&G), Coca-Cola (KO), and Johnson & Johnson (JNJ), which typically trade at a Price-to-Earnings (P/E) ratio under 20

PajamaBoyz

https://preview.redd.it/70s57sathbzf1.png?width=1344&format=png&auto=webp&s=7b196c27130b3ec5023dab519af948a85b37f005 34% drawdown on this specific set for 670s is roughly $5k in size. Keep in mind these trades pictured are only for SPY & Qs. I am also short a few other names like NVDA, SMH, AMZN, AAPL, BAC, JNJ, etc...

WayAgreeable3999

Nah it has nothing to do with trumps drop. The lawsuits in the uk are a massive liability that is the reason the company split from JNJ. Lawsuits for asbestos in the talc.

No_Art_2787

Im a vascular IR RN. Its cool tech. Super small demographic. Tons of pharma solutions for clots that dont require a level 1. JNJ shockwave has a larger customer base potential.

GetOutMeSwaamp

Not a JNJ attorney but typical reasons for not settling these early include: 1) too high of a demand from the plaintiff; 2) uncertain liability exposure; 3) other co-defendants who share some portion of liability; 4) they don’t want to set a precedent of eagerly settling claims; and/or 5) the financial risk makes it worth trying the case and hoping for a defense verdict.

Always_Curious_One2

I believe SMWB is an outstanding under covered stock. 100% recurring revenues from subscription data services that are growing 15-17% new subscriptions every year. 45% of the subscriptions are multiple year. 80% gross margins and only trading at 2X their revenue They are cash flow positive and expect at $400mm revenue margins will be 25%. Their data is used by global enterprises to do competitive analysis and adjust go to market strategies between web, mobile, Gen AI They serve clients in all industries from Google to JNJ to Coke to DHL to GM to JP Morgan etc. Their data is constantly updated with their feeds from global internet locations - and the AI Models Pay SMWB to feed their analyses - they need the constantly updated data. It’s an $8 stock that will earn at least $1 in a few years - and likely will get a 25-30X multiple for a high margin, growing, capital light, global data recurring subscription standard.

Maggins

My wife and I are in healthcare and work with this population. Not only are they not the sole market leader, they have lots of competition in that particular area of medicine. I have friends that work for competitor companies (JNJ, Medtronic), so I get to hear about all the upcoming “will change medicine” technologies they are working on. Most of these technologies will never become successful. And the ones that do have a relatively small market and a very slow uptake rate. I personally would never invest in medical technology companies. It’s too difficult to predict which ones will see stock gains, and usually those gains are short lived.

Vermillionbird

JNJ owns the liability for the baby powder lawsuits, not KVUE

Last_Cauliflower3357

I own 500 shares at 16 dollars. Strong brands, mature business and very good dividend. I’ve looked into the lawsuits and I honestly believe they don’t matter. The Tylenol one is dumb. They’re only stuck with non-US and Canada talc lawsuits and my view is that it’s fine, damages are only outrageous in the US and JNJ is being able to reduce payments on those significantly in appeals. I am cautiously optimistic for the new CEO search. If they get much lower than this, they’ll get bought. So I am still very confident in my investment.

stickman07738

Personally, I stuck with JNJ fully because KVUE is actually a commoditized business with the only value being brand names - just too much generic competition.

rxs126

Why isn’t JNJ actively trying to settle these before going deep into litigation? Why would they ever risk going to a decision? Or is this just a blood in the water situation and no one is willing to ate to an early settlement?

Always_Curious_One2

I believe SMWB is an outstanding under covered stock. 100% recurring revenues from subscription data services that are growing 15-17% new subscriptions every year. 45% of the subscriptions are multiple year. 80% gross margins and only trading at 2X their revenue They are cash flow positive and expect at $400mm revenue margins will be 25%. Their data is used by global enterprises to do competitive analysis and adjust go to market strategies between web, mobile, Gen AI They serve clients in all industries from Google to JNJ to Coke to DHL to GM to JP Morgan etc. Their data is constantly updated with their feeds from global internet locations - and the AI Models Pay SMWB to feed their analyses - they need the constantly updated data. It’s an $8 stock that will earn at least $1 in a few years - and likely will get a 25-30X multiple for a high margin, growing, capital light, global data recurring subscription standard.

seraphimkoamugi

Not entirely sure how the whole: "it goes down when the dividends are paid" works since I invest on ETFS right now, Dividend & Growth etfs, but the price of companies don't necessarily go down all that much or if they do it might be for a week or so. Just basing this on stocks like JNJ, PG, PEP and ABBV. They only keep going up and they pay $1/share per dividend payout and their stocks don't necessarily go down one dollar for long. I do have reservations investing on anything thats on the red during their 5 year to MAX tenure graphs. Though if I'm incorrect I'd appreciate a clarification since that could help with deciding better company stocks.

GetOutMeSwaamp

As a defense attorney I don’t agree with it either. Especially because it is virtually impossible to identify the asbestos contents of products that were distributed 50+ years ago. I saw the JNJ verdict read live yesterday, couldn’t believe it. I have clients who are being sued in asbestos litigation where the territories that the alleged exposure took place weren’t even in their distribution chains.

GetOutMeSwaamp

$JNJ is done. There are tens of thousands of lawsuits pending against JNJ for alleged asbestos exposure due to the talc contained in their powder products, which wasn’t discontinued until 2020. In October 2025, a Los Angeles jury ordered JNJ to pay $966 million in a talc/mesothelioma case for a woman who died of mesothelioma, finding asbestos in the talc product.  Earlier in 2025, a Massachusetts jury awarded $42.6 million to a man who developed mesothelioma after using JNJ baby powder.  There are also numerous other verdicts: a $260 million verdict in Oregon (June 2024), a $45 million verdict in Illinois (April 2024) for a mesothelioma wrongful-death case, and a $20 million verdict in Broward County, FL against JNJ was rendered yesterday afternoon.  Forget about the Tylenol case, asbestos litigation is what will drive $JNJ into the ground.

GetOutMeSwaamp

More than 60,000 lawsuits are pending against JNJ in the U.S. for talc-related claims. In October 2025, a Los Angeles jury ordered JNJ to pay $966 million in a talc/mesothelioma case for a woman who died of mesothelioma, finding asbestos in the talc product.  Earlier in 2025, a Massachusetts jury awarded $42.6 million to a man who developed mesothelioma after using JNJ baby powder.  There are also numerous other verdicts: a $260 million verdict in Oregon (June 2024), a $45 million verdict in Illinois (April 2024) for a mesothelioma wrongful-death case, and a $20 million verdict in Broward County, FL against JNJ was rendered yesterday afternoon.  With tens of thousands of pending lawsuits the sheer scale amplifies exposure. Even modest per-claim settlements or judgments can aggregate to multi-billion-dollar sums. Also, Texas just sued JNJ for the risks associated with Tylenol, which serves as even more exposure. I don’t see a way for $JNJ to be a safe play by any means.

crashumbc

Instructions unclear, down 70% on JNJ call from yesterday (was up 30% at one point:( Is this when I sell or do I hold till Fri?

Last_Cauliflower3357

Have a look at their annual report my dude. Page 32 has a full description of the risk and they have another description surrounding their relationship with JNJ. Just copying a few paragraphs that may be interesting for you. In October 2021, Old JJCI implemented a corporate restructuring, as a result of which LTL Management LLC (“LTL”), a subsidiary of J&J, was established through a demerger procedure and assumed sole responsibility for all liabilities of Old JJCI related in any way to injury or damage, or alleged injury or damage, sustained or incurred in the purchase or use of, or exposure to, talc, including talc contained in any product sold in the United States or Canada, or to the risk of, or responsibility for, any such damage or injury, including such liabilities based on the contamination, or alleged contamination, of talc, including talc contained in any product sold in the United States and Canada, with asbestos or any other material (the “Talc-Related Liabilities”). Pursuant to the Separation Agreement, J&J has retained the Talc-Related Liabilities and, as a result, has agreed to indemnify us for the Talc-Related Liabilities and any costs associated with resolving such claims. Such claims represent the vast majority of claims relating to harm arising out of, based upon or resulting from, directly or indirectly, the presence of or exposure to talc or talc-containing products. However, we remain responsible for all liabilities on account of or relating to harm arising out of, based upon or resulting from, directly or indirectly, the presence of or exposure to talc or talc-containing products sold outside the United States or Canada. LTL remains a subsidiary of J&J (and not Kenvue) following the Separation. 32 We cannot predict with certainty the amount or timing of Talc-Related Liabilities that LTL or J&J will be required to pay, whether in connection with the bankruptcy proceedings or otherwise. Various parties have brought, and it is possible that other parties will seek to bring, claims against us, including by raising allegations that we are liable for the Talc-Related Liabilities, and it is possible that these parties will be successful in bringing such claims. Although, under the Separation Agreement, J&J has agreed to indemnify us for the Talc-Related Liabilities and any costs associated with resolving such claims, we cannot assure you that the indemnity from J&J will be sufficient to protect us against the full amount of these liabilities or that J&J will be able to fully satisfy its indemnification obligations. See “— Risks Related to Our Relationship with J&J—In connection with the Separation, J&J agreed to indemnify us for certain liabilities. However, we cannot assure you that the indemnity will be sufficient to protect us against the full amount of such liabilities or that J&J’s ability to satisfy its indemnification obligation will not be impaired in the future.”

Vivid-Avocado9342

The lawsuit was about JNJ knowing there was a possibility that their talc powers were contaminated with cancer causing asbestos, and doing nothing to inform the public of the risk. The two aren’t the same because science has already proven that asbestos is a cancer causing agent, and lawyers everywhere know saying otherwise in court is not going to fly. The same can’t be said for acetaminophen. The plaintiff will need to be able to use evidence to demonstrate to a jury that, 1) acetaminophen causes cancer, 2) Kenvue knew that acetaminophen causes cancer and sold it anyway. This lawsuit is the equivalent of a political stunt and will very likely lead to counter suits. (Just like all those voting machine fraud allegations lead to counter lawsuits a couple elections back)

EmpathyFabrication

Texas AG suing KVUE and JNJ over Tylenol autism link lol

euro1127

This is such an obvious pump and dump. Don Cheeto is pissed that JNJ didn't want to play ball like Pfizer for his grift site so he is tanking the stock him and a bunch of friends are get in after all the negative news piles in then surprise cased dismissed don pulls a taco and the pump and dump ensues

skilliard7

Because that's the precedent. JNJ got sued over talc powder despite there being no conclusive evidence that it caused cancer. Why? Because they can't prove that it didn't cause cancer. They have tried to settle multiple times for Billions of dollars, and been shot down every time.

Last_Cauliflower3357

The Tylenol murders were caused by this dude that tampered with the Tylenol bottles at a store. He even confessed and tried to extort money from JNJ through it, the DOJ files indicate that they were pretty sure he did it but didn’t have sufficient evidence to charge him.

farshid13

Notable Option Flow Recap Big money still pouring into multiple sectors today 👇 • $BULL 35C (11/21/2025) – 💰 $431K @ 0.12 avg | 204% OTM • $EOSE 21C (01/16/2026) – ⚡ $814K @ 2.06 avg | 31% OTM (ER in 11 D) • $GM 80C (03/20/2026) – 🚗 $2.3M @ 2.19 avg | 15% OTM • $HUT 75C (01/15/2027) – 💻 $2.2M @ 14.23 avg | 57% OTM (ER in 11 D) • $JNJ 195C (11/21/2025) – 🧬 $1.9M @ 1.64 avg • $PATH 20C (01/16/2026) – 🤖 $19.6M @ 1.30 avg | 21% OTM • $PDD 138C (11/28/2025) – 🛍️ $14.3M @ 5.09 avg • $RDDT 250C (11/07/2025) – 💬 $2.4M @ 6.59 avg | 17% OTM (ER in 6 D) • $TLT 94C (03/31/2026) – 🏦 $2.7M @ 1.96 avg • $UUUU 33C (10/31/2025) – ☢️ $387K @ 1.27 avg | 54% OTM (Buzzer Beater) 🧠 Smart money spreading risk across growth, energy, and macro trades — both short-term momentum and long-dated conviction plays. 💡 Simplest way to see what the big boys are doing — use real-time AI data from Perplexity Browser 👇 👉 https://pplx.ai/maxmasoodi63049

farshid13

Notable Option Flow Recap Big money still pouring into multiple sectors today 👇 • $BULL 35C (11/21/2025) – 💰 $431K @ 0.12 avg | 204% OTM • $EOSE 21C (01/16/2026) – ⚡ $814K @ 2.06 avg | 31% OTM (ER in 11 D) • $GM 80C (03/20/2026) – 🚗 $2.3M @ 2.19 avg | 15% OTM • $HUT 75C (01/15/2027) – 💻 $2.2M @ 14.23 avg | 57% OTM (ER in 11 D) • $JNJ 195C (11/21/2025) – 🧬 $1.9M @ 1.64 avg • $PATH 20C (01/16/2026) – 🤖 $19.6M @ 1.30 avg | 21% OTM • $PDD 138C (11/28/2025) – 🛍️ $14.3M @ 5.09 avg • $RDDT 250C (11/07/2025) – 💬 $2.4M @ 6.59 avg | 17% OTM (ER in 6 D) • $TLT 94C (03/31/2026) – 🏦 $2.7M @ 1.96 avg • $UUUU 33C (10/31/2025) – ☢️ $387K @ 1.27 avg | 54% OTM (Buzzer Beater) 🧠 Smart money spreading risk across growth, energy, and macro trades — both short-term momentum and long-dated conviction plays. 💡 Simplest way to see what the big boys are doing — use real-time AI data from Perplexity Browser 👇 👉 https://pplx.ai/maxmasoodi63049

Last_Cauliflower3357

The US trials do not matter for KVUE, they have an agreement with JNJ to get indemnified in case they are found liable in US and Canada. Compensation in lawsuits outside North America is usually much smaller in case of being found liable.

Last_Cauliflower3357

They’re not going to 0, chill. The asbestos baby powder thing is unproven and the UK trials work in a different manner. It’s an actual judge taking a decision with the scientific reasoning and not a jury of common people being influenced by media and outrage. The UK also rarely awards punitive damages. JNJ is appealing all rulings and mostly getting those punitive damages reduced significantly. I own 400 shares of KVUE. This is their main risk, more than anything in the business. Nevertheless, my view at this point is the UK trial needs to be monitored but I believe it won’t move the needle significantly. They’re trying to get 1bn of damages which would be fine for KVUE. Sell if you can’t handle the volatility but I am holding and may buy more. You should’ve done your homework on this before buying though.

musiro77

[https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l](https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l) Live for Trumps speech

musiro77

[https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l](https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l)

ThinkingOfTheOldDays

oof, hurt by JNJ paper hands

dangernext

I think today I will chill out, dump my money in JNJ at open. Play BF6 and come pick it up end of day.

humtake

Which is so stupid considering one move by China that has very little impact in the near-term is overshadowing the incredible news from JP, Wells Fargo, JNJ, etc. So far, the only bad economic news that impacts anything is GM's loss assumption but that is just based on EVs and not any long-term fundamental problem. But, all of the good economic news is getting ignored so far this morning which is freaking stupid. What China did sucks but it has almost no bearing on anything in the short term which just illustrates more that our market is driven by emotion than actual facts and figures.

GargantuasGoose

This shit sentiment has fucked my DPZ and JNJ calls smh

Agreeable-Poet2409

Just buy JNJ

Stocks_N_Bondage

- ACI Put - JNJ Diagonal Strangle DPZ and ERIC no trade, if I did then a put I think, but it seems priced in to where there won't be enough of a move due to IV crush, etc.

SpyBagholder

All pharma stocks should print this week JNJ sold a fuck load of GLPs

BrandonLeeOfficial

Spent the afternoon at the driving range working through my weak points from the tourney last week. Pops stopped by, bought a hat, talked shit, then left. He should be the one practicing, but never admits wrong doing. therapist will hear about this. How y’all feeling about JNJ earnings? $200 lottos if I don’t sleep in.

SBTC_Strays_2002

Calls on JNJ

EcstaticWear5903

!Banbet JNJ 195 1 week

manitou202

The only ones on my list the held up were Gold, JNJ, PG, TLT, TLH. Gold, long bonds, and non-tech blue chips.

manitou202

Your best bet is to simply diversify. Buy some foreign ETFs, buy some long term bonds, gold, non-tech blue chip stocks like WMT, XOM, PG, JNJ, JPM, etc, and keep a small amount in tech. If the bubble pops, AI/tech stocks and meme stocks will take big hits, but the rest of the market may be relatively okay. When the dot com bubble burst, the SP500 was down about 35% while the NASDAQ went down 60-70%. The DOW (only 30 stocks) was down less than 20%. Many big blue chip companies continued to climb in value while also paying dividends. Gold continued up.

Kowabungaaa1

JNJ?